Form 4: 10x Genomics Director Sells Shares
Insider Transaction (Form 4)
Shehnaaz Suliman, a Director of 10x Genomics, Inc., sold 5,723 shares of common stock on September 22, 2026.
Summary
- Open-market sale: disposed of 292 Class A Common Stock at $78.20 ($22,833) on September 22, 2026; holds 29,223 after (Direct).
- Open-market sale: disposed of 614 Class A Common Stock at $79.51 ($48,820) on September 22, 2026; holds 28,609 after (Direct).
- Open-market sale: disposed of 1,325 Class A Common Stock at $80.82 ($107,082) on September 22, 2026; holds 27,284 after (Direct).
- Open-market sale: disposed of 2,270 Class A Common Stock at $81.67 ($185,391) on September 22, 2026; holds 25,014 after (Direct).
- Open-market sale: disposed of 1,222 Class A Common Stock at $82.28 ($100,542) on September 22, 2026; holds 23,792 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $464,668 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Shehnaaz Suliman — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Open-market sale | Class A Common Stock | 292 | $78 | $22.8K | 29,223 |
| 2026-09-22 | Open-market sale | Class A Common Stock | 614 | $80 | $48.8K | 28,609 |
| 2026-09-22 | Open-market sale | Class A Common Stock | 1,325 | $81 | $107.1K | 27,284 |
| 2026-09-22 | Open-market sale | Class A Common Stock | 2,270 | $82 | $185.4K | 25,014 |
| 2026-09-22 | Open-market sale | Class A Common Stock | 1,222 | $82 | $100.5K | 23,792 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Open-market sale (292 shares) |
| 2026-09-22 | Open-market sale (614 shares) |
| 2026-09-22 | Open-market sale (1,325 shares) |
| 2026-09-22 | Open-market sale (2,270 shares) |
| 2026-09-22 | Open-market sale (1,222 shares) |
Keywords
insider transaction, Form 4, TXG, 10x Genomics, Inc., bearish, Shehnaaz Suliman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.